94 results
Page 4 of 5
S-4/A
EX-10.16
n1d bm294
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
cum qudfd
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-8.1
mung83 6oc9
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.11
dq7cyva54aipsj
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
h7042k
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
h6v5gqdyx4vsu792
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
oqk4v l974wgb73cwlnz
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
w1h0mabwikrtp7 y10n
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
bnm125a4xoq dibur
15 Mar 21
Business combination disclosure
8:20am
8-K
tpi8avs gu8x1auywr0
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
vxo toscodhlgj
5 Mar 21
Annual report
8:13am
10-Q
d5u881
20 Aug 20
Quarterly report
4:15pm
8-K
EX-99.1
bqv1uwp
16 Jul 20
Report of Independent Registered Public Accounting Firm
4:30pm
8-K
EX-10.1
fbsqss
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm